CUBIST PHARMACEUTICALS INC
CBST
CBST was delisted on the 21st of January, 2015.
271 hedge funds and large institutions have $6.18B invested in CUBIST PHARMACEUTICALS INC in 2013 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 93 increasing their positions, 107 reducing their positions, and 30 closing their positions.
286% more call options, than puts
Call options by funds: $317M | Put options by funds: $82.1M
67% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 30
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
7% more funds holding
Funds holding: 254 → 271 (+17)
5% less capital invested
Capital invested by funds: $6.53B → $6.18B (-$352M)
13% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 107
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$89.4M |
| 2 |
O
OrbiMed
New York
|
+$49.2M |
| 3 |
State Street
Boston,
Massachusetts
|
+$39M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$35.9M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$32.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$472M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$40.8M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$38.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$31.2M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$26.2M |
CBST Hedge Fund Activity: Q3 2013 in Review
271 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q3 2013, worth a combined $6.18B — down 5.4% from $6.53B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new CBST positions and 30 closed out — a net gain of 20 holders — while 93 added to existing stakes and 107 trimmed.
The largest buyer was Putnam Investments, adding an estimated $89.4M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $472M.
- 271 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q3 2013, up from 254 in Q2 2013.
- Funds reported $6.18B of CUBIST PHARMACEUTICALS INC stock for Q3 2013, down 5.4% quarter-over-quarter.
- 50 funds opened new CUBIST PHARMACEUTICALS INC positions in Q3 2013 and 30 closed out, a net change of +20 holders.
- The largest CUBIST PHARMACEUTICALS INC buyer in Q3 2013 was Putnam Investments, an estimated $89.4M added.
- The largest CUBIST PHARMACEUTICALS INC seller in Q3 2013 was BNP Paribas Financial Markets, an estimated $472M sold.
Based on aggregated 13F filings for Q3 2013.